Table 1. Univariate analysis for... | American Society of Hematology

Table 1.

Univariate analysis for survival

	Patients, n	Patients, %	Median survival, mo	P
Cytogenetics*				< .0001
Good	262	50	27
Intermediate	108	20	22
Poor	159	30	7
Sex				.9073
Female	188	34	16
Male	365	66	15
Age				.0217
60 y or younger	185	33	18
Older than 60 y	368	67	13
Hemoglobin				.0024
Less than 10 g/dL	355	64	13
10 g/dL or greater	198	36	19
Absolute neutrophil count				.9314
Less than 1.5 K/μL	291	53	16
1.5 K/μL or greater	262	47	14
Platelets				< .0001
Less than 100 K/μL	370	67	12
100 K/μL or more	183	33	28
BM blasts, %†				.0056
Less than 5	181	33	27
5-10	149	27	14
11-20	145	26	12
21-30	76	14	16
B2M				< .0001
2 mg/L or less	158	29	32
Greater than 2 mg/L	395	71	13
Intensive treatment				.0150
Yes	271	49	14
No	282	51	18
Creatinine level				.2249
Less than 1 mg/dL	308	56	16
1 mg/dL or greater	245	44	14

	Patients, n	Patients, %	Median survival, mo	P
Cytogenetics*				< .0001
Good	262	50	27
Intermediate	108	20	22
Poor	159	30	7
Sex				.9073
Female	188	34	16
Male	365	66	15
Age				.0217
60 y or younger	185	33	18
Older than 60 y	368	67	13
Hemoglobin				.0024
Less than 10 g/dL	355	64	13
10 g/dL or greater	198	36	19
Absolute neutrophil count				.9314
Less than 1.5 K/μL	291	53	16
1.5 K/μL or greater	262	47	14
Platelets				< .0001
Less than 100 K/μL	370	67	12
100 K/μL or more	183	33	28
BM blasts, %†				.0056
Less than 5	181	33	27
5-10	149	27	14
11-20	145	26	12
21-30	76	14	16
B2M				< .0001
2 mg/L or less	158	29	32
Greater than 2 mg/L	395	71	13
Intensive treatment				.0150
Yes	271	49	14
No	282	51	18
Creatinine level				.2249
Less than 1 mg/dL	308	56	16
1 mg/dL or greater	245	44	14

Data available for 529 patients.

Data available for 551 patients.